A recent directive by the Ministry of Health said 'Oseltamivir Phosphate' and 'Zanamivir' drugs have now been included in the Schedule H1 category of the Drugs and Cosmetics Act. Earlier, these drugs belonged to Schedule X category and were available in a restricted number of chemist shops.
The Drug Controller General of India (DCGI) had issued a notice earlier this year revoking its September 15, 2009, notification which had restricted the sale of these drugs for H1N1 as specified under Schedule X.
Patients will now have to produce a medical prescription from a certified doctor to buy the drugs.
Manufacturers of these drugs will have to submit to the DCGI a monthly statement of the quantity of medicines supplied to distributors, stockists, dealers etc.
Besides, pharmacies will have to maintain the sale of such drugs in a separate register for three years.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)